Brandes Investment increases stake in Grifols’ B shares to 16.4%

grifols edificio

Alphavalue/DIVACONS | Brandes Investment Partners has taken advantage of the sharp fall in the stock market value of the Catalan company specialising in plasma products following the tariff crisis to increase its stake in the B shares (non-voting) to 16.4%, with an estimated value of €250 million. This position could be key if Brookfield decides to resume its takeover bid for the company. Grifols shares rose 6.63% on Thursday.

Grifols: Buy, Target Price €15/share.

About the Author

The Corner
The Corner has a team of on-the-ground reporters in capital cities ranging from New York to Beijing. Their stories are edited by the teams at the Spanish magazine Consejeros (for members of companies’ boards of directors) and at the stock market news site Consenso Del Mercado (market consensus). They have worked in economics and communication for over 25 years.